Healthcare provider profile · identity verified

Long Hoang Le, MD

Internal Medicine · ALPHARETTA, GA · NPI 1962493650

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	469	145
Amlodipine Besylate	Amlodipine Besylate	401	113
Montelukast Sodium	Montelukast Sodium	373	128
Losartan Potassium	Losartan Potassium	303	82
Atorvastatin Calcium	Atorvastatin Calcium	288	84
Levothyroxine Sodium	Levothyroxine Sodium	284	76
Metoprolol Succinate	Metoprolol Succinate	273	80
Lisinopril	Lisinopril	261	72
Gabapentin	Gabapentin	190	63
Hydrochlorothiazide	Hydrochlorothiazide	170	49
Trazodone Hcl	Trazodone Hcl	170	55
Glimepiride	Glimepiride	151	43
Ezetimibe	Ezetimibe	134	42
Omeprazole	Omeprazole	122	36
Metformin Hcl	Metformin Hcl	118	33
Simvastatin	Simvastatin	112	30
Allopurinol	Allopurinol	108	28
Metformin Hcl Er	Metformin Hcl	108	31
Escitalopram Oxalate	Escitalopram Oxalate	87	24
Carvedilol	Carvedilol	76	23
Prednisone	Prednisone	76	63
Pantoprazole Sodium	Pantoprazole Sodium	75	26
Pravastatin Sodium	Pravastatin Sodium	62	16
Tramadol Hcl	Tramadol Hcl	62	12
Alendronate Sodium	Alendronate Sodium	60	16
Tamsulosin Hcl	Tamsulosin Hcl	53	18
Finasteride	Finasteride	50	15
Eliquis	Apixaban	49	14
Fenofibrate	Fenofibrate	47	15
Synthroid	Levothyroxine Sodium	41	11
Potassium Chloride	Potassium Chloride	39	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Sertraline Hcl	Sertraline Hcl	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	24
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Azithromycin	Azithromycin	32	26
Furosemide	Furosemide	32	suppressed
Testosterone Cypionate	Testosterone Cypionate	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	12
Diclofenac Sodium	Diclofenac Sodium	30	12
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Atenolol	Atenolol	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Valsartan	Valsartan	14	suppressed
Estradiol	Estradiol	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Testosterone	Testosterone	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Digoxin	Digoxin	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Levoxyl	Levothyroxine Sodium	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error